Seeking Alpha
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

How Regeneron Pharmaceuticals, Sanofi, And Amgen Will Weather The Inevitable Price Wars

Drug development in the U.S. has always been a high-risk, high-reward business. Companies take huge risks to develop a drug through years of clinical development, in exchange for pricing freedom in the most drug-consuming country in the world. But the last three months have been a blow of sorts to the drug development industry, as Express Scripts' (NASDAQ:ESRX) deal with AbbVie (NYSE:ABBV) threatens the free market nature of drug pricing in the U.S. While not all drug types face the same risk created by Express Scripts and AbbVie, there is one upcoming blockbuster set of drugs that will likely follow suit - PCSK9 inhibitors to lower bad cholesterol. Here's why, and what factors will affect price wars in the drug pricing…